Patents by Inventor Cy Aaron Stein

Cy Aaron Stein has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TKI permeability enhancers
    Patent number: 11759530
    Abstract: Provided herein are, inter alia, methods useful for delivering nucleic acids and kinase inhibitors to a cell. The methods provided herein include the delivery of therapeutic nucleic acids to cancer cells by contacting a cancer cell with a kinase inhibitor and a therapeutic nucleic acid. The methods provided herein are therefore, inter alia, useful for the treatment of cancer.
    Type: Grant
    Filed: November 17, 2015
    Date of Patent: September 19, 2023
    Assignee: City of Hope
    Inventors: Cy Aaron Stein, Daniela Castanotto, David Horne
  • TREATMENT OF PROSTATE CANCER
    Publication number: 20170157148
    Abstract: Described herein are compounds, methods of making such compounds, pharmaceutical compositions, and medicaments comprising such compounds, and methods of using such compounds to treat androgen receptor mediated diseases or conditions. The present invention provides therapies and therapeutic regimens for the treatment of prostate cancer.
    Type: Application
    Filed: February 23, 2017
    Publication date: June 8, 2017
    Inventors: Jodie Pope Morrison, Cy Aaron Stein, David Scott Casebier
  • Treatment of prostate cancer
    Patent number: 9156878
    Abstract: Described herein are compounds, methods of making such compounds, pharmaceutical compositions, and medicaments comprising such compounds, and methods of using such compounds to treat androgen receptor mediated diseases or conditions. The present invention provides therapies and therapeutic regimens for the treatment of prostate cancer.
    Type: Grant
    Filed: June 24, 2014
    Date of Patent: October 13, 2015
    Assignee: Tokai Pharmaceuticals, Inc.
    Inventors: Jodie Pope Morrison, Cy Aaron Stein, David Scott Casebier
  • TREATMENT OF PROSTATE CANCER
    Publication number: 20150203528
    Abstract: Described herein are compounds, methods of making such compounds, pharmaceutical compositions, and medicaments comprising such compounds, and methods of using such compounds to treat androgen receptor mediated diseases or conditions. The present invention provides therapies and therapeutic regimens for the treatment of prostate cancer.
    Type: Application
    Filed: March 2, 2015
    Publication date: July 23, 2015
    Inventors: Jodie Pope Morrison, Cy Aaron Stein, David Scott Casebier
  • TREATMENT OF PROSTATE CANCER
    Publication number: 20150166599
    Abstract: Described herein are compounds, methods of making such compounds, pharmaceutical compositions, and medicaments comprising such compounds, and methods of using such compounds to treat androgen receptor mediated diseases or conditions. The present invention provides therapies and therapeutic regimens for the treatment of prostate cancer.
    Type: Application
    Filed: March 2, 2015
    Publication date: June 18, 2015
    Inventors: Jodie Pope Morrison, Cy Aaron Stein, David Scott Casebier
  • TREATMENT OF PROSTATE CANCER
    Publication number: 20140343024
    Abstract: Described herein are compounds, methods of making such compounds, pharmaceutical compositions, and medicaments comprising such compounds, and methods of using such compounds to treat androgen receptor mediated diseases or conditions. The present invention provides therapies and therapeutic regimens for the treatment of prostate cancer.
    Type: Application
    Filed: June 24, 2014
    Publication date: November 20, 2014
    Inventors: Jodie Pope Morrison, Cy Aaron Stein, David Scott Casebier
  • Treatment of prostate cancer
    Patent number: 8791094
    Abstract: Described herein are compounds, methods of making such compounds, pharmaceutical compositions, and medicaments comprising such compounds, and methods of using such compounds to treat androgen receptor mediated diseases or conditions. Such compounds include inhibitors of cytochrome C17?-hydroxylase/C17,20-lyase such as 3-?-Hydroxy-17-(1H-benzimidazol-1-yl)androsta-5,16-diene.
    Type: Grant
    Filed: August 5, 2010
    Date of Patent: July 29, 2014
    Assignee: Tokai Pharmaceuticals, Inc.
    Inventors: Jodie Pope Morrison, Cy Aaron Stein, David Scott Casebier
  • Treatment of Prostate Cancer
    Publication number: 20110034428
    Abstract: Described herein are compounds, methods of making such compounds, pharmaceutical compositions, and medicaments comprising such compounds, and methods of using such compounds to treat androgen receptor mediated diseases or conditions. The present invention provides therapies and therapeutic regimens for the treatment of prostate cancer.
    Type: Application
    Filed: August 5, 2010
    Publication date: February 10, 2011
    Applicant: TOKAI PHARMACEUTICALS, INC.
    Inventors: Jodie Pope Morrison, Cy Aaron Stein, David Scott Casebier